Form D · Other Health Care
B2M Medical, Inc.
Irvine, CA · CIK 0001912787
Offering snapshot reported Mar 9, 2022 · SEC filing
- Reported sold
- $825K Offering amount: $1.8M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2022 | Initial | $825,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436498
Series Seed Preferred Stock
Source: Form D, filed Mar 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexei V. Babkin | Director |
| Michael R. Henson | Director |
| Rafi Mazor | Director |
| Maria Nevarez | Executive |
| Edmund J. Roschak | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
30 Fairbanks, Suite 100
Irvine, CA, 92618
Irvine, CA, 92618